Want to join the conversation?
$ZBH posted a narrower loss in 2Q16, helped by higher sales and operating profit compared to 2Q15. Net loss was $31.3MM or $0.16 per diluted share, an increase from a net loss of $173.6MM or $1.00 per diluted share in the prior year period. Net sales of $1.93Bil grew 65.6% from last year. Adjusted diluted EPS was $2.02 in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?